ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,399,179, issued on Aug. 26, was assigned to Liquid Biopsy Research LLC (Charlestown, Saint Kitts and Nevis).

"Chemical compositions and methods of use" was invented by Irvin Mark Modlin (Woodbridge, Conn.), Mark Kidd (New Haven, Conn.) and Ignat Drozdov (Stratford Upon Avon, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to methods for detecting a melanoma, methods for determining whether a melanoma is stable or progressive, methods for evaluating the extent of surgery resection in a subject having a melanoma, and methods for determining a response by a subject having a melanoma to a therapy."

The patent ...